tiprankstipranks
Onconetix (ONCO)
NASDAQ:ONCO
US Market

Onconetix (ONCO) Income Statement

Compare
212 Followers

Onconetix Income Statement

Last quarter (Q4 2025), Onconetix's total revenue was $303.60K, a decrease of -57.36% from the same quarter last year. In Q4, Onconetix's net income was $5.67M. See Onconetix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 815.37K$ 2.52M$ 58.47K$ 0.00$ 0.00
Gross Profit
$ 632.91K$ 1.06M$ -1.13M$ -6.75K$ -4.89K
Operating Expenses
$ 6.98M$ 57.54M$ 34.91M$ 13.48M$ 3.42M
Depreciation and Amortization
$ 15.17K$ 731.35K$ 43.94K$ 6.75K$ 4.89K
EBITDA
$ -6.33M$ -57.60M$ -36.71M$ -13.41M$ -3.41M
Operating Income
$ -6.34M$ -56.49M$ -36.03M$ -13.48M$ -3.42M
Other Income/Expenses
$ -7.69M$ -3.25M$ -1.39M$ 61.41K$ 0.00
Pretax Income
$ -14.03M$ -59.74M$ -37.42M$ -13.42M$ -3.42M
Net Income
$ -14.03M$ -58.69M$ -37.41M$ -13.42M$ -3.42M
Per Share Metrics
Basic EPS
$ -4.73$ -520.93$ -25.03$ -0.31$ -0.09
Diluted EPS
$ -4.73$ -520.93$ -25.03$ -0.31$ -0.09
Weighted Average Shares Outstanding
3.28M 113.05K 17.61K--
Weighted Average Shares Outstanding (Diluted)
3.28M 113.05K 17.61K--
Currency in USD

Onconetix Earnings and Revenue History